Sinew Pharma Inc. (TPEX: 6634)
Taiwan
· Delayed Price · Currency is TWD 67.30
+0.40 (0.60%)
Sep 11, 2024, 9:00 AM CST
Sinew Pharma Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Cash & Equivalents | 109.17 | 166.81 | 246.68 | 551.17 | 46.82 | 252.72 | Upgrade
|
| Short-Term Investments | 1,103 | 1,109 | 1,144 | 931.49 | 291.49 | 39.99 | Upgrade
|
| Cash & Short-Term Investments | 1,213 | 1,275 | 1,391 | 1,483 | 338.31 | 292.71 | Upgrade
|
| Cash Growth | -9.63% | -8.31% | -6.17% | 338.25% | 15.58% | 138.00% | Upgrade
|
| Accounts Receivable | - | - | - | - | 0.15 | - | Upgrade
|
| Other Receivables | 22.93 | 18.87 | 16.3 | 14.3 | 13.04 | 11.95 | Upgrade
|
| Receivables | 22.93 | 18.87 | 16.3 | 14.3 | 13.19 | 11.95 | Upgrade
|
| Prepaid Expenses | 1.05 | 1.09 | 0.63 | 4.22 | - | - | Upgrade
|
| Other Current Assets | - | - | - | - | 0.4 | 1.24 | Upgrade
|
| Total Current Assets | 1,237 | 1,295 | 1,408 | 1,501 | 351.9 | 305.9 | Upgrade
|
| Property, Plant & Equipment | 12.94 | 18.86 | 14.35 | 4.51 | 7.72 | 11.53 | Upgrade
|
| Other Intangible Assets | 30.08 | 38.51 | 55.58 | 67.23 | 83.33 | 95.59 | Upgrade
|
| Other Long-Term Assets | 13.64 | 10.55 | 9.15 | 11.84 | 10.22 | 7.76 | Upgrade
|
| Total Assets | 1,293 | 1,363 | 1,487 | 1,585 | 453.16 | 420.78 | Upgrade
|
| Accrued Expenses | 14.45 | 22.9 | 15.36 | 10.56 | 7.79 | 8.18 | Upgrade
|
| Current Portion of Leases | 6.1 | 6.46 | 2.99 | 1.05 | 2.29 | 1.84 | Upgrade
|
| Current Unearned Revenue | 0.52 | 0.52 | 0.52 | 0.85 | - | - | Upgrade
|
| Other Current Liabilities | 6.75 | 5.31 | 4.38 | 2.65 | 5.42 | 237.8 | Upgrade
|
| Total Current Liabilities | 27.83 | 35.19 | 23.25 | 15.11 | 15.49 | 247.82 | Upgrade
|
| Long-Term Leases | - | 2.82 | 4.56 | - | 1.05 | 3.34 | Upgrade
|
| Other Long-Term Liabilities | 1.7 | 1.7 | 0.85 | 0.85 | 0.85 | 0.85 | Upgrade
|
| Total Liabilities | 29.53 | 39.71 | 28.66 | 15.96 | 17.4 | 252.01 | Upgrade
|
| Common Stock | 713.34 | 711.66 | 697.72 | 690.09 | 522.9 | 383.2 | Upgrade
|
| Additional Paid-In Capital | 813.53 | 808.87 | 900.96 | 1,067 | 218.64 | 12.55 | Upgrade
|
| Retained Earnings | -244.8 | -170.92 | -140.18 | -188.43 | -305.78 | -226.98 | Upgrade
|
| Comprensive Income & Other | -18.31 | -25.95 | - | 0.43 | - | - | Upgrade
|
| Shareholders' Equity | 1,264 | 1,324 | 1,459 | 1,569 | 435.76 | 168.77 | Upgrade
|
| Total Liabilities & Equity | 1,293 | 1,363 | 1,487 | 1,585 | 453.16 | 420.78 | Upgrade
|
| Total Debt | 6.1 | 9.28 | 7.55 | 1.05 | 3.34 | 5.18 | Upgrade
|
| Net Cash (Debt) | 1,207 | 1,266 | 1,384 | 1,482 | 334.97 | 287.53 | Upgrade
|
| Net Cash Growth | -9.25% | -8.49% | -6.61% | 342.31% | 16.50% | 133.79% | Upgrade
|
| Net Cash Per Share | 16.97 | 17.97 | 19.97 | 24.90 | 6.72 | 7.52 | Upgrade
|
| Filing Date Shares Outstanding | 71.33 | 71.17 | 69.77 | 69.01 | 52.29 | 38.32 | Upgrade
|
| Total Common Shares Outstanding | 71.33 | 71.17 | 69.77 | 69.01 | 52.29 | 38.32 | Upgrade
|
| Working Capital | 1,209 | 1,260 | 1,385 | 1,486 | 336.41 | 58.07 | Upgrade
|
| Book Value Per Share | 17.72 | 18.60 | 20.90 | 22.73 | 8.33 | 4.40 | Upgrade
|
| Tangible Book Value | 1,234 | 1,285 | 1,403 | 1,502 | 352.43 | 73.18 | Upgrade
|
| Tangible Book Value Per Share | 17.29 | 18.06 | 20.11 | 21.76 | 6.74 | 1.91 | Upgrade
|
| Machinery | 12.93 | 12.75 | 7.11 | 5.83 | 3.65 | 2.43 | Upgrade
|
| Leasehold Improvements | 11.28 | 11.28 | 9.31 | 4.96 | 4.96 | 4.89 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.